etilefrine has been researched along with Prostatic Hyperplasia in 1 studies
Etilefrine: A phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Serrate, RG | 1 |
| Prats, J | 1 |
| Regué, R | 1 |
| Rius, G | 1 |
1 other study available for etilefrine and Prostatic Hyperplasia
| Article | Year |
|---|---|
The usefulness of ethylephrine (Efortil-R) in the treatment of priapism and intraoperative penile erections.
Topics: Aged; Aged, 80 and over; Anesthesia, Spinal; Etilefrine; Humans; Injections; Intraoperative Period; | 1992 |